SEC Form 4 · accession 0001562180-16-003199
PROGENICS PHARMACEUTICALS INC · PGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bryce Tenbarge
Officer — Vice President, Commercial
Period of report
Oct 3, 2016
Accepted (ET)
Oct 4, 2016 · 2:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000835887
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy)F1 | $6.77 | Oct 3, 2016 | A | 75,000 | A | — | Oct 3, 2026 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F15yr 20% On Vest beginning on 01-SEP-2016